Noninvasive Scoring Systems for Persons With Chronic Liver Disease: Are They Ready for Prime Time?
Nonalcoholic fatty liver disease (NAFLD) is currently among the most common causes of chronic liver disease liver disease worldwide, affecting ≥25% of the global adult population and a prevalence that exceeds 55% in individuals with type 2 diabetes mellitus.1,2 The potentially progressive form of NAFLD, nonalcoholic steatohepatitis (NASH), can advance to advanced fibrosis and cirrhosis; it is responsible for an increasing number of cases of hepatocellular carcinoma, liver transplantation, and/or death in the United States.
Source: Gastroenterology - Category: Gastroenterology Authors: Zobair M. Younossi, Linda Henry Tags: Editorial Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fatty Liver Disease (FLD) | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Non-alcoholic Fatty Liver Diseases (NAFLD) | Transplants | Urology & Nephrology | USA Health